Global Thrombus Aspiration Catheter Market Size, Share, and COVID-19 Impact Analysis, By Types (Hydrophilic and Lumen), By End User (Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Thrombus Aspiration Catheter Market Size Insights Forecasts to 2035

• The Global Thrombus Aspiration Catheter Market Size Was Estimated at USD 1.96 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.99% from 2025 to 2035
• The Worldwide Thrombus Aspiration Catheter Market Size is Expected to Reach USD 5.05 Billion by 2035

Key Takeaways -

• North America dominated the market with the largest share in 2024. 
• Asia Pacific is expected to grow the fastest during the forecast period.
• By types, the hydrophilic segment dominates the thrombus aspiration catheter market, while lumen is the emerging segment in the market.
• By end user, the hospital segment is anticipated to hold the dominant share, on the other hand, clinics segment is emerging in the thrombus aspiration catheter market.

According to a research report published by Spherical Insights and Consulting, the Global Thrombus Aspiration Catheter Market size was worth around USD 1.96 Billion in 2024 and is predicted to grow to around USD 5.05 Billion by 2035 with a compound annual growth rate (CAGR) of 8.99% from 2025 and 2035. The market for medical thrombus aspiration catheter has a number of opportunities to grow due to the increasing prevalence of cardiovascular/stroke and technological advancement in the device.

Key Trends in Medical Thrombus Aspiration Catheter Market –

• Technological Advancements in Catheter Tip Design for Thrombectomy
• Emerging Minimally Invasive Techniques and AI-Powered Smart Technology Navigation Tools
• Strategic Industrial Expansion by companies like Penumbra and Medtronic to diversify product portfolios

Market Overview

The global medical thrombus aspiration catheter industry is the market encompassing specialized medical devices used in minimally invasive procedures for removing blood clots (thrombi) from vascular systems, primarily treating myocardial infarction, acute ischemic stroke, and peripheral arterial diseases. Thrombus aspiration is the medical procedure involving manual removal of a blood clot (thrombus) from a blood vessel during percutaneous coronary intervention (PCI) to improve myocardial perfusion and reduce adverse cardiac events in patients with acute MI.

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures and the expanding partnerships. For instance, in April 2022, MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, announced the first patient enrollments in a multicenter clinical study to assess the safety and performance of the Q Aspiration Catheter used in a combined aspiration with stent-retriever technique for thrombus removal in patients who suffered an acute ischemic stroke.     

Report Coverage

This research report categorizes the thrombus aspiration catheter market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the thrombus aspiration catheter market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the thrombus aspiration catheter market. 

Driving Factors

Growing prevalence of cardiovascular diseases and deep vein thrombosis (DVT)

It was estimated that deep vein thrombosis (DVT) affects approximately 1.6 per 1,000 adults annually, while cardiovascular diseases, including heart attacks and strokes, are the leading causes of global mortality. It is reported by Endovascular Today report that ClotTriever System is the leading device used for intervening in DVT, with a prospective research demonstrating excellent safety and effectiveness of MT for acute to chronic DVT.  

Adoption of Interventional Cardiology Procedures

Thrombus aspiration is an interventional cardiology procedure used during percutaneous coronary intervention (PCI) to remove blood clots (thrombi) from coronary arteries, typically in STEMI patients. Further, an increasing preference for minimally invasive procedures over open-heart surgery is driving the adoption of interventional cardiology devices, which is anticipated to propel the market

.

Further, the combined usage of stentrievers (ADAPT technique), extension catheters, and specialized guide wires to optimize navigation and suction contributes to accelerating the thrombus aspiration catheter market.

Restraining Factors

Increased cost and need for specialized training

An increased cost of advanced aspiration catheters and specialized training to healthcare professionals for operating the devices are challenging factors in the market.

Market Segmentation

The Thrombus Aspiration Catheter Market share is classified into types and end user.   

• The hydrophilic segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the thrombus aspiration catheter market is divided into hydrophilic and lumen. Among these, the hydrophilic segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. This is due to its enhanced lubricity and ease of navigation in complex vascular anatomies. The catheters are designed for use in vascular emergencies like stroke or coronary artery disease for efficient clot removal. For instance, Zoom 7X, Pronto, and SOFIA, featuring a hydrophilic coating for smoother navigation, high flexibility, and strong vacuum suction for removing thromboemboli. While the lumen segment is the emerging segment in the thrombus aspiration catheter market, due to its usage under a wide procedural technique known as aspiration thrombectomy.    

• The hospitals segment accounted for the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the thrombus aspiration catheter market is divided into hospitals, clinics, and others. Among these, the hospitals segment accounted for the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The availability of specialized medical infrastructure and skilled professionals for performing the procedures contributes to driving the segmental market growth. Thrombus aspiration catheters are used in hospital cardiac catherization labs for removing thrombi during emergencies such as STEMI or acute ischemic stroke. Further, the clinics segment is a growing segment driven by an increasing number of interventional cardiology procedures and the need for less invasive treatment options.

Regional Segment Analysis of the Thrombus Aspiration Catheter Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the thrombus aspiration catheter market over the predicted timeframe.

North America is anticipated to hold the largest share of about 35.0% in the thrombus aspiration catheter market over the predicted timeframe. The market ecosystem in North America is strong, due to the increasing number of FDA-approved techniques for thrombus removal. For instance, in December 2024, Brandon Hospital launched an FDA-approved technique for blood clot removal. The demand for medical thrombus aspiration catheters has been driven by the region's increasing prevalence of cardiovascular and stroke cases, with an ageing population. The U.S. is leading the North America thrombus aspiration catheter market, due to increased adoption of advanced cardiovascular devices, large patient population, and presence of well-known industries like Medtronic, Stryker, and Penumbra, Inc.

Asia Pacific is expected to grow at a rapid CAGR of approximately 8.0% in the thrombus aspiration catheter market during the forecast period. The Asia Pacific area has a thriving market for medical thrombus aspiration catheters due to the growing prevalence of cardiovascular diseases, sedentary lifestyles, and technological innovations in the medical field. Due to their governments’ increased investment in medical technology and an increasing technological advancement in devices, the market is expected to grow. China and Japan are the leading countries in the region’s market, owing to robust growth driven by an increasing cardiovascular disease prevalence, an ageing population, and the adoption of minimally invasive procedures.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Thrombus Aspiration Catheter Market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• SAI Infusion Technologies
• AMG International
• HEXACATH
• Stentys
• Nipro
• Medtronic Inc.
• Eucatech
• Biotronik
• Endocor
• Teleflex
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In March 2026, Perfuze, a medical device company dedicated to advancing stroke treatment through next-generation catheter technology, announced it had received FDA 510(k) clearance for the Millipede88 Aspiration Catheter.

• In January 2024, Penumbra, Inc., a thrombectomy company, has secured CE Mark (Conformité Européenne) for its Indigo System CAT RX designed to address the limitations of traditional management strategies in acute coronary syndrome (ACS).

• In November 2021, Springer Medizin published an open-access report article on the topic Comparison of Aspiration Catheters with Modified Standard Catheters for Treatment of Large Pulmonary Embolism Using an In-vitro Patho-Physiological Model’.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Thrombus Aspiration Catheter Market based on the below-mentioned segments:  

Global Thrombus Aspiration Catheter Market, By Types

• Hydrophilic
• Lumen

Global Thrombus Aspiration Catheter Market, By End User

• Hospitals
• Clinics
• Others

Global Thrombus Aspiration Catheter Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa